 | • レポートコード：QYR2104Z0308 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、肛門がん治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（フルオロウラシル、シスプラチン、カルボプラチン）、用途別市場規模（病院、介護センター、薬局、診断研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・肛門がん治療薬の市場動向 ・企業の競争状況、市場シェア ・肛門がん治療薬の種類別市場規模（フルオロウラシル、シスプラチン、カルボプラチン） ・肛門がん治療薬の用途別市場規模（病院、介護センター、薬局、診断研究所） ・肛門がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・肛門がん治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・肛門がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・肛門がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・肛門がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline Pharmaceuticals、Spectrum Pharmaceuticals、Hospira、Global BioPharma、Advaxis） ・結論 |
A cancer can be defined when the normal cells lose their ability to control, their growth or multiplication and thus invade the tissues and spread to the body parts. Anal cancer is often called as squamous cell carcinoma which arises from the cells around or in the anal opening or in rare cases it may cause in the anal canal. This type of cancer is usually associated with human papiloma virus (HPV), where HPV cancers or cervical cancers have a high risk of developing into anal cancer. There are no exact symptoms for anal cancer as such but some might show bleeding from the anal area, lump or swelling near anus or change in the bowel habits etc. Staging is a way which describes the location of cancer, the stages include tumor, node and metastasis which is further grouped I, II, IIIA, IIIB and IV. The different types of anal cancer include melanoma, adenocarcinoma, basaloid transitional and cloacogenic cancer.
The statistics for anal cancer suggest that annually there about 6000 cases of anal cancer diagnosed in the U.S. and the number is increasing slowly. The major factors that drive the market for anal cancer therapeutics are aging population, sexually transmitted disease, multiple sexual partners and smoking. According to the World Health Organization 290 million women are suffering from HPV infection and due to unhealthy sex, the chances get doubled. For treating this anal cancer, early diagnosis is crucial which is only available in the developed countries or high-income countries and are accessible. Whereas in the low-income countries the diagnosis and treatment facilities are either costly or inaccessible. These factors are responsible for holding back the anal cancer therapeutics market and should be well tracked for future advancements.
Market Analysis and Insights: Global Anal Cancer Therapeutics Market
The global Anal Cancer Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anal Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anal Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anal Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anal Cancer Therapeutics market.
Global Anal Cancer Therapeutics Scope and Market Size
Anal Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anal Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Fluorouracil
Cisplatin
Carboplatin
Segment by Application
Hospitals
Long-Term Care Centers
Pharmacies
Diagnostic Laboratories
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GlaxoSmithKline Pharmaceuticals
Spectrum Pharmaceuticals
Hospira
Global BioPharma
Advaxis
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anal Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fluorouracil
1.2.3 Cisplatin
1.2.4 Carboplatin
1.3 Market by Application
1.3.1 Global Anal Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Long-Term Care Centers
1.3.4 Pharmacies
1.3.5 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anal Cancer Therapeutics Market Perspective (2016-2027)
2.2 Anal Cancer Therapeutics Growth Trends by Regions
2.2.1 Anal Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Anal Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Anal Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Anal Cancer Therapeutics Industry Dynamic
2.3.1 Anal Cancer Therapeutics Market Trends
2.3.2 Anal Cancer Therapeutics Market Drivers
2.3.3 Anal Cancer Therapeutics Market Challenges
2.3.4 Anal Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anal Cancer Therapeutics Players by Revenue
3.1.1 Global Top Anal Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Anal Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Anal Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Anal Cancer Therapeutics Revenue
3.4 Global Anal Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Anal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anal Cancer Therapeutics Revenue in 2020
3.5 Anal Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Anal Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Anal Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anal Cancer Therapeutics Breakdown Data by Type
4.1 Global Anal Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Anal Cancer Therapeutics Forecasted Market Size by Type (2022-2027)
5 Anal Cancer Therapeutics Breakdown Data by Application
5.1 Global Anal Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Anal Cancer Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Anal Cancer Therapeutics Market Size (2016-2027)
6.2 North America Anal Cancer Therapeutics Market Size by Type
6.2.1 North America Anal Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Anal Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Anal Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Anal Cancer Therapeutics Market Size by Application
6.3.1 North America Anal Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Anal Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Anal Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Anal Cancer Therapeutics Market Size by Country
6.4.1 North America Anal Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Anal Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Anal Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Anal Cancer Therapeutics Market Size by Type
7.2.1 Europe Anal Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Anal Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Anal Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Anal Cancer Therapeutics Market Size by Application
7.3.1 Europe Anal Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Anal Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Anal Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Anal Cancer Therapeutics Market Size by Country
7.4.1 Europe Anal Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Anal Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Anal Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Anal Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Anal Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Anal Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Anal Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Anal Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Anal Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Anal Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Anal Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Anal Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Anal Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Anal Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anal Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Anal Cancer Therapeutics Market Size by Type
9.2.1 Latin America Anal Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Anal Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Anal Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Anal Cancer Therapeutics Market Size by Application
9.3.1 Latin America Anal Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Anal Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Anal Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Anal Cancer Therapeutics Market Size by Country
9.4.1 Latin America Anal Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Anal Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anal Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Anal Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Anal Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Anal Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Anal Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Anal Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Anal Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Anal Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Anal Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Anal Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Anal Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Anal Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline Pharmaceuticals
11.1.1 GlaxoSmithKline Pharmaceuticals Company Details
11.1.2 GlaxoSmithKline Pharmaceuticals Business Overview
11.1.3 GlaxoSmithKline Pharmaceuticals Anal Cancer Therapeutics Introduction
11.1.4 GlaxoSmithKline Pharmaceuticals Revenue in Anal Cancer Therapeutics Business (2016-2021)
11.1.5 GlaxoSmithKline Pharmaceuticals Recent Development
11.2 Spectrum Pharmaceuticals
11.2.1 Spectrum Pharmaceuticals Company Details
11.2.2 Spectrum Pharmaceuticals Business Overview
11.2.3 Spectrum Pharmaceuticals Anal Cancer Therapeutics Introduction
11.2.4 Spectrum Pharmaceuticals Revenue in Anal Cancer Therapeutics Business (2016-2021)
11.2.5 Spectrum Pharmaceuticals Recent Development
11.3 Hospira
11.3.1 Hospira Company Details
11.3.2 Hospira Business Overview
11.3.3 Hospira Anal Cancer Therapeutics Introduction
11.3.4 Hospira Revenue in Anal Cancer Therapeutics Business (2016-2021)
11.3.5 Hospira Recent Development
11.4 Global BioPharma
11.4.1 Global BioPharma Company Details
11.4.2 Global BioPharma Business Overview
11.4.3 Global BioPharma Anal Cancer Therapeutics Introduction
11.4.4 Global BioPharma Revenue in Anal Cancer Therapeutics Business (2016-2021)
11.4.5 Global BioPharma Recent Development
11.5 Advaxis
11.5.1 Advaxis Company Details
11.5.2 Advaxis Business Overview
11.5.3 Advaxis Anal Cancer Therapeutics Introduction
11.5.4 Advaxis Revenue in Anal Cancer Therapeutics Business (2016-2021)
11.5.5 Advaxis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Anal Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fluorouracil
Table 3. Key Players of Cisplatin
Table 4. Key Players of Carboplatin
Table 5. Global Anal Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Anal Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Anal Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Anal Cancer Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Anal Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Anal Cancer Therapeutics Market Share by Regions (2022-2027)
Table 11. Anal Cancer Therapeutics Market Trends
Table 12. Anal Cancer Therapeutics Market Drivers
Table 13. Anal Cancer Therapeutics Market Challenges
Table 14. Anal Cancer Therapeutics Market Restraints
Table 15. Global Anal Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Anal Cancer Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Anal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anal Cancer Therapeutics as of 2020)
Table 18. Ranking of Global Top Anal Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Anal Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Anal Cancer Therapeutics Product Solution and Service
Table 22. Date of Enter into Anal Cancer Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Anal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Anal Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Anal Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Anal Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Anal Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Anal Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Anal Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Anal Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Anal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Anal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Anal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Anal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Anal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Anal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Anal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Anal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Anal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Anal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Anal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Anal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Anal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Anal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Anal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Anal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Anal Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Anal Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Anal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Anal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Anal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Anal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Anal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Anal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Anal Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Anal Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Anal Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Anal Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Anal Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Anal Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. GlaxoSmithKline Pharmaceuticals Company Details
Table 63. GlaxoSmithKline Pharmaceuticals Business Overview
Table 64. GlaxoSmithKline Pharmaceuticals Anal Cancer Therapeutics Product
Table 65. GlaxoSmithKline Pharmaceuticals Revenue in Anal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 66. GlaxoSmithKline Pharmaceuticals Recent Development
Table 67. Spectrum Pharmaceuticals Company Details
Table 68. Spectrum Pharmaceuticals Business Overview
Table 69. Spectrum Pharmaceuticals Anal Cancer Therapeutics Product
Table 70. Spectrum Pharmaceuticals Revenue in Anal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Spectrum Pharmaceuticals Recent Development
Table 72. Hospira Company Details
Table 73. Hospira Business Overview
Table 74. Hospira Anal Cancer Therapeutics Product
Table 75. Hospira Revenue in Anal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Hospira Recent Development
Table 77. Global BioPharma Company Details
Table 78. Global BioPharma Business Overview
Table 79. Global BioPharma Anal Cancer Therapeutics Product
Table 80. Global BioPharma Revenue in Anal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Global BioPharma Recent Development
Table 82. Advaxis Company Details
Table 83. Advaxis Business Overview
Table 84. Advaxis Anal Cancer Therapeutics Product
Table 85. Advaxis Revenue in Anal Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Advaxis Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anal Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Fluorouracil Features
Figure 3. Cisplatin Features
Figure 4. Carboplatin Features
Figure 5. Global Anal Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Long-Term Care Centers Case Studies
Figure 8. Pharmacies Case Studies
Figure 9. Diagnostic Laboratories Case Studies
Figure 10. Anal Cancer Therapeutics Report Years Considered
Figure 11. Global Anal Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Anal Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anal Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Anal Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Anal Cancer Therapeutics Market Share by Players in 2020
Figure 16. Global Top Anal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anal Cancer Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Anal Cancer Therapeutics Revenue in 2020
Figure 18. Global Anal Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Anal Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Anal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Anal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Anal Cancer Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Anal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Anal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Anal Cancer Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Anal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Anal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Anal Cancer Therapeutics Market Share by Region (2016-2027)
Figure 40. China Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Anal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Anal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Anal Cancer Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Anal Cancer Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Anal Cancer Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Anal Cancer Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Anal Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GlaxoSmithKline Pharmaceuticals Revenue Growth Rate in Anal Cancer Therapeutics Business (2016-2021)
Figure 60. Spectrum Pharmaceuticals Revenue Growth Rate in Anal Cancer Therapeutics Business (2016-2021)
Figure 61. Hospira Revenue Growth Rate in Anal Cancer Therapeutics Business (2016-2021)
Figure 62. Global BioPharma Revenue Growth Rate in Anal Cancer Therapeutics Business (2016-2021)
Figure 63. Advaxis Revenue Growth Rate in Anal Cancer Therapeutics Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
世界の肛門がん市場規模・現状・予測（2021年-2027年） Anal cancer is a disease in which malignant (cancer) cells form in the tissues of the anus. Being infected with the human papillomavirus (HPV) increases the risk of developinganal cancer. Signs of anal cancer include bleeding from theanus or rectum or a lump near the anus. Market Analysis and Insigh…- 世界の肛門がん市場 2021：企業別、地域別、種類・用途別 The Anal Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent…
- 世界の肛門・大腸がん市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anal and Colorectal Cancer Market The global Anal and Colorectal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界の肛門・大腸がん市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Anal and Colorectal Cancer Market The global Anal and Colorectal Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, …
- 世界の裂肛治療市場規模・現状・予測（2021年-2027年） An anal fissure is a painful medical condition where the anal canal has been torn and is accompanied by pain and bleeding during and after defecation. Market Analysis and Insights: Global Anal Fissure Treatment Market The global Anal Fissure Treatment market size is projected to reach US$ 2398.2 mil…